Multidisciplinarity and interdisciplinarity in medicine and education as a tool for improving the quality of patients’ antitumor treatment

Cover Page

Cite item

Full Text

Abstract

Relevance. Despite the advances in modern medicine, the improvement of treatment methods for many diseases, the overall incidence of cancer, as well as mortality from cancer, remains high. At the same time, the approaches to antitumor treatment themselves often significantly reduce the quality of life of patients, limit their ability to work, which causes certain social and economic damage from these diseases. In this regard, issues of improving the quality of antitumor treatment are among the priority issues in healthcare today. The purpose of this study is to find new possible tools and approaches to improve the quality of antitumor treatment for patients at different levels, including clinical and educational. It is possible to significantly change and improve the quality of oncological care for patients through the tools and technologies of accompanying therapy, including dental support, the clinical significance of which is critically underestimated today. Improving the methods of accompanying therapy is a multidisciplinary problem that can and should be solved exclusively in the context of interdisciplinary interaction of specialists of different profiles. Currently, the development of dental support is limited by a number of factors, such as clinical or organizational, but one of the most significant factors is the insufficient focus on this problem in medical education. Of course, the current pace of development of medicine, the introduction of new technologies, including artificial intelligence, increase the requirements for a modern specialist doctor and require extensive knowledge that goes beyond one discipline, including the presence of interdisciplinary thinking. Conclusion.Thus, the introduction of interdisciplinary approaches in the training of future dentists and doctors specializing in «General Medicine», training students at the intersection of different specialties (oncology and dentistry, dentistry and hematology) can improve the quality of dental support in particular, and the quality of antitumor treatment in general.

About the authors

Anatoliy M. Avanesov

RUDN University

Email: gvozdikova_en@pfur.ru
ORCID iD: 0000-0003-4068-7698
SPIN-code: 7091-8276
Moscow, Russian Federation

Vera A. Titova

Russian Scientific Center of Roentgenoradiology

Email: gvozdikova_en@pfur.ru
ORCID iD: 0000-0002-8037-594X
SPIN-code: 2562-4392
Moscow, Russian Federation

Evgeniya N. Gvozdikova

RUDN University; Russian Scientific Center of Roentgenoradiology

Author for correspondence.
Email: gvozdikova_en@pfur.ru
ORCID iD: 0000-0002-5426-1084
SPIN-code: 9410-6747
Moscow, Russian Federation

References

  1. Kaprin AD, Starinsky VV, Shakhzadova AO. The state of oncological care for the population of Russia in 2023. Moscow: P.A. Herzen Moscow Oncology Research Institite — branch of the National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation; 2024.239 p. (In Russian).
  2. Shakhzadova AO, Starinsky VV, Lisichnikova IV. The state of cancer care for the population of Russia in 2022. Siberian journal of oncology. 2023;22(5):5–13. (In Russian).
  3. Alymov YuV, Ignatova A., Romanov IS. Clinical guidelines and expediency of using 5‑aminolevulinic acid for intraoperative visualization of margins of malignant tumors of the oral cavity. Head and Neck Tumors (HNT). 2022;12(2):33–40. (In Russian)
  4. Gevorkov A R, Boyko AV, Bolotina LV, Shashkov SV, Abuzarova GR, Sarmanaeva RR. Results of implementation of a program of individual support of chemoradiation therapy in patients with head and neck tumors. Head and Neck Tumors (HNT). 2020;10(4): 60–73. doi: 10.17650/2222-1468-2020-10-4-60-73
  5. Elad S, Cheng KKF, Lalla RV, Yarom N, Hong C, Logan R M, Bowen J, Gibson R, Saunders DP, Zadik Y, Ariyawardana A, Correa ME, Ranna V, Bossi P. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2020;126(19):4423–4431. doi: 10.1002/cncr.33100
  6. Andreev PY, Moshurov IP, Korotkih NV. Malignant neoplasms ozone therapy. RUDN Journal of Medicine. 2024;28(4):466–487. doi: 10.22363/2313-0245-2024-28-4-466-487 (In Russian).
  7. Aedinova IV, Volkova VL, Svetitsky PV, Bauzhadze MV, Islamova EF. Surgical treatment of cancer of the mucous membrane of the posterior parts of the oral cavity and oropharynx using mandibulotomy. Modern problems of science and education. 2016;3:23–27. (In Russian)
  8. Titova VA, Snigireva GP, Petrovsky YuV, Telysheva E N. Modern approaches to radiation treatment of oral tumors. Siberian journal of oncology. 2016;15(5):47–54. (In Russian).
  9. Artamonova EV, Bazin IS, Baranova OYu, Besova NS, Boychenko EI. Guide to chemotherapy of tumor diseases. Practical Medicine. 2018. 686 p. (In Russian).
  10. Kopnin BP. Neoplastic cell: main properties and mechanisms of occurrence. Practical Oncology. 2002;4:229–235. (In Russian).
  11. Rivera F, García-­Castano A, Vega N, Vega-­Villegas ME, Gutierrez-­Sanz L. Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial. Expert Rev. Anticancer Ther. 2009;9(10):1421–1428.
  12. Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, Erfan J, Zabolotnyy D, Kienzer H R, Cupissol D, Peyrade F, Benasso M, Vynnychenko I, De Raucourt D, Bokemeyer C, Schueler A, Amellal N, Hitt R. Platinum-­based chemotherapy plus cetuximab in head and neck cancer. N. Engl. J. Med. 2008;359(11):116–1127.
  13. Safarov DA, Mudunov AM, Dolgushin BI, Akhundov AA, Zaderenko IA, Peshko DA. Results of conservative treatment of locally advanced larynx squamous cell carcinoma using intraarterial regional polychemotherapy. Head and Neck Tumors (HNT). 2021;11(1):41–50. (In Russian.)
  14. Kamsvåg T, Svanberg A, Legert KG, Arvidson J, von Essen L, Mellgren K, Toporski J, Winiarski J, Ljungman G. Prevention of oral mucositis with cryotherapy in children undergoing hematopoietic stem cell transplantations-a feasibility study and randomized controlled trial. Support. Care Cancer. 2020;28:1–11.
  15. Scully C, Epstein J, Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy, and radiochemotherapy: part 1, pathogenesis and prophylaxis of mucositis. Head Neck. 2003;25(12):1057–1070. doi: 10.1002/hed.10318
  16. Epstein JB, Schubert MM. Managing pain in mucositis. Semin Oncol Nurs. 2004;20(1):30–37. doi: 10.1053/j.soncn.2003.10.006
  17. Argiris A, Brockstein B E, Haraf DJ, Stenson KM, Mittal BB, Kies MS, Rosen F R, Jovanovic B, Vokes EE. Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clin Cancer Res. 2004;10:1956–1962.
  18. Lapteva ES, Aryev AL, Tsutsunava MR. Comorbidity/multimorbidity problem of terminology and application of index indicators. Advances in gerontology. 2021;34(3):336–344. (In Russian).
  19. Jumaniyazova ED, Sentyabreva AV, Kosyreva A.M, Lokhonina AV. Molecular genetic signatures of head and neck squamous cell carcinoma and their changes induced by proton irradiation. RUDN Journal of Medicine. 2024;28(4):413–426. doi: 10.22363/2313-0245-2024-28-4-413-426 (In Russian).
  20. Mudunov AM, Pak MB, Wolf LYa. The role of nutritional support in treatment of head and neck tumors: clinical case. Head and Neck Tumors (HNT). 2022;12(3):86–94. (In Russian).
  21. Dzhereley AA, Romanenko IG, Arakelyan КA, Kryuchkov DY, Gorobets SМ, Bobkova SA. Correlation features of oral mucosits and psychological status in patients with squamous cell carcinoma of the oral mucosa at the stage of chemoradiation therapy. Bulletin of the Medical Institute «REAVIZ». 2021;(2):100–105. (In Russian).
  22. Reyes-­Gibby CC, Wang J, Zhang L, Peterson CB, Do KA, Jenq RR, Shelburne S, Shah DP, Chambers MS, Hanna EY, Yeung SJ, Shete S. Oral Microbiome and Onset of Oral Mucositis in Patients with Squamous Cell Carcinoma of the Head and Neck. Cancer. 2020;126(23):5124–36. doi: 10.1002/cncr.33161
  23. Bagirova NS, Petukhova IN, Grigorievskaya ZV, Sytov A, Slukin PV, Goremykina EA, Khokhlova OE, Fursova NK, Kazimov AE. Oral microbiota in patients with oropharyngeal cancer with an emphasis on Candida spp. Head and Neck Tumors (HNT). 2022;12(3):71–85. (In Russian).
  24. Hong BY, Sobue T, Choquette L, Dupuy AK, Thompson A, Burleson JA, Salner AL, Schauer PK, Joshi P, Fox E, Shin DG, Weinstock GM, Strausbaugh LD, Dongari-­Bagtzoglou A, Peterson DE, Diaz PI. Chemotherapy-­induced oral mucositis is associated with detrimental bacterial dysbiosis. Microbiome. 2019;7(1):66. doi: 10.1186/s40168-019-0679-5
  25. Shikhlyarova AI, Zhukova GV. Pathophysiological aspects of the use of accompanying therapy in oncology. Crimean Journal of Experimental and Clinical Medicine. 2020;10 (3):124. (In Russian).
  26. Ballyuzek MF, Ionova AK, Mashkova MV, Stepanov BP, Chagunava OL. Organization of rehabilitation programs for cancer patients based on an interdisciplinary approach. Research and Practical Medicine Journal. 2018;5(4):91–97. (In Russian).
  27. Velcheva AI, Zenkevich AA, Boshataev DT. Oral mucositis as a complication of polychemotherapy. Academic Journal of Western Siberia. 2022;18(2):25–28 (In Russian).
  28. Golubev PV, Bolotina LV, Gevorkov AR, Deshkina TI, Boyko AV, Kaprin AD. The effectiveness of a dual-component regimen of induction chemotherapy in the treatment of HPV-positive oropharyngeal squamous cell carcinoma. Siberian journal of oncology. 2023;22(2):26–33. (In Russian).
  29. Blakaj A, Bonomi M, Gamez ME, Blakaj DM. Oral mucositis in head and neck cancer: Evidence-­based management and review of clinical trial data. Oral Oncol. 2019;95:29–34. doi: 10.1016/j.oraloncology.2019.05.013
  30. Kusiak A, Jereczek-­Fossa BA, Cichońska D, Alterio D. Oncological-­Therapy Related Oral Mucositis as an Interdisciplinary Problem-­Literature Review. Int J Environ Res Public Health. 2020;17(7):2464. doi: 10.3390/ijerph17072464
  31. Kudasova EO, Kochurova EV, Nikolenko VN, Panferova OI. Dental treatment of patients with squamous cell carcinoma of the oral mucosa. Russian Dental Journal. 2021;25(3):259–268. (In Russian).
  32. Kasoev VG, Gabaraev DE. Mucositis as a complication of antitumor therapy. Prevention and principles of treatment. Scientific Leader. 2023;4(102):41–43. (In Russian). https://scilead.ru/article/3938‑mukozit-kak-oslozhnenie-­protivoopukholevoj-te
  33. Dharman S, Shanmugasundaram K, Sampath RK. A Systematic Review and Meta-­Analysis on the Efficacy of Curcumin/Turmeric for the Prevention and Amelioration of Radiotherapy/Radiochemotherapy Induced Oral Mucositis in Head and Neck Cancer Patients. Asian Pac J Cancer Prev. 2021;22(6):1671–1684. doi: 10.31557/APJCP.2021.22.6.1671
  34. Alcantara MJ, Pandy JG, Sebastian MR. 338P — Vitamin E in the treatment of chemotherapy and radiation-­induced mucositis: A meta-analysis of randomized controlled trials. Ann Oncol. 2020;31(6):1371–1377. https://doi.org/10.1016/j.annonc.2020.10.332
  35. Brown TJ, Gupta A. Management of cancer therapy-­associated oral mucositis. JCO Oncol Pract. 2020;16:103–9. doi: 10.1200/JOP.19.00652
  36. Sultanov RR. Interdisciplinary interaction of doctors as one of the ways to increase the effectiveness of the treatment process. Humanities and Social Sciences. 2013;2:231–243. (In Russian).
  37. Roitberg GE, Tyulkina EE, Dorosh ZhV, Filatov RE, Anikeeva OYu. Organization of multidisciplinary rehabilitation of oncology patients. Bulletin of Restorative Medicine. 2019;5(93):14–20. (In Russian).
  38. Kostin AA, Samsonov YV. Management structure and organization of oncological careю. RUDN Journal of Medicine. 2024;28.(2):206–215. doi: 10.22363/2313-0245-2024-28-2-206-215
  39. Lopanova EV, Lalov Yu V. Integration of medical and pedagogical technologies in the professional training of a future doctor. Problems of modern science and education. 2017;14(96):72–78. (In Russian).
  40. Bergen TA, Pukhalsky AN. Multidisciplinarity and interdisciplinarity as opportunities for the development of the system of medical care in the Russian Federation. Bulletin of Roszdravnadzor. 2023; 1:28–34. (In Russian).
  41. Aksenova EI. Organization of the work of interdisciplinary teams in primary healthcare. Moscow Medicine. 2023;1(53):34–41. (In Russian).
  42. Martykenova DS, Aimbetova GE, Bagiyarova FA. Foreign experience in the functioning of multidisciplinary teams of psycho-­social profile in outpatient clinics. Bulletin of KazNMU. 2019;2: 378–381. (In Russian).
  43. Pavlovsky VV. Distinctive features of our advanced training programs are focus on practice and interdisciplinarity. Doctor.Ru. 2022;2. (In Russian).

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».